The immune response to islets in experimental diabetes and insulin dependent diabetes mellitus

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 860-864

  Wegmann, Dale R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL DIABETES MELLITUS; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; SHORT SURVEY; T LYMPHOCYTE;

EID: 0030443713     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80016-1     Document Type: Article

References (39)

1. 1. Bottazzo GF, Florin-Christensen A, Doniach D: Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974, 2:1279-1283.
2. 2. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337-1339.
3. 3. Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
4. 4. Dotta F, Lenti L, Dionisi S, Casetta B, D'Erme M, Eisenbarth GS, Di Mario U: GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 1995, 38:1-5.
5. 5. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992, 41:183-186.
6. 6. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994, 152:3183-3188.
7. 7. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994, 13:505-514.
8. 8. Solimena M, Dirkx R, Hermel J-M, Pleasic-Williams S, Shapiro JA, Caron L, Rabin DU: ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 1996, 15:2102-2114.
9. 9. Lu J, Notkins AL, Lan MS: Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Commun 1994, 204:930-936.
10. 10. Magistrelli G, Covini N, Mosca M, Lippoli G, Isacchi A: Expression of PTP35, the murine homolog of the protein tyrosine phosphatase-related sequence IA-2, is regulated during cell growth and stimulated by mitogens in 3T3 fibroblasts. Biochem Biophys Res Commun 1995, 217:154-161.
11. 11. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000 and 40,000-Mr trypic fragments of islet antigens in insulin-dependent diabetes and to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995, 96:1506-1511.
12. 12. Wasmeier C, Hutton JC: Molecular cloning of Phogrin, a protem-tyrosine phosphatase homologue localized to insulin secretory granule membranne. J Biol Chem 1996, 271:18161-18170.
13. 13. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattrock M, Fonte M-T, Bottazzo G-F, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994, 43:1304-1310.
14. 14. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45:926-933. These two references, [13,14], illustrate the remarkable progress that has been made over the past several years in the development of screening assays that are applicable to screening large numbers of individuals for risk of IDDM.
15. 15. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from the NOD mouse. Eur J Immunol 1994, 25:1056-1062.
16. 16. Schloot NC, Daniel D, Norbury-Glaser M, Wegmann DR: Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity. J Autoimmun 1996, 9:367-363.
17. 17. Dallas-Pedretti A, McDuffie M, Haskins K: A diabetes-associated T cell autoantigen maps to a telomeric locus on mouse chromosome 6. Proc Natl Acad Sci USA 1995, 92:1386-1390.
18. 18. Neophytou PI, Muir EM, Hutton CJ: A subtractive cloning approach to the identification of mRNAs specifically expressed in pancreatic β-cells. Diabetes 1996, 45:127-133.
19. 19. Neophytou PI, Roep BO, Arden SD, Muir EM, Duinkerken G, Kallan A, De Vires RRP, Hutton JC: T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38 kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient Proc Natl Acad Sci USA 1996, 93:2014-2018. This paper describes a method for expression of cDNA library products for screening for T cell antigenicity. This approach should allow the identification of antigens present in beta cells that are recognized by autoreactive T cell lines and clones.
20. 20. Durinovic-Bello I, Hummel M, Ziegler A-G: Cellular Immune response to diverse islet cell antigens in IDDM. Diabetes 1996, 45:795-800.
21. 21. Nepom GT: Glutamic acid decarboxylase and other autoantigens in IDDM. Curr Opin Immunol 1995, 7:825-830.
22. 22. Yang Y, Charlton B, Shimada A, Canto RD, Fathman CG: Monoclonal T cells identified in early NOD islet infiltrates. Cell 1996, 4:189-194.
23. + T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996, 157:978-983.
24. 24. Peterson JD, Haskins K: Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirements for CD8 T cells. Diabetes 1996, 45:328-336.
25. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996, 26:1762-1769. See annotation [26].
26. + T cells isolated from infiltrates resulting from spontaneous disease are capable of beta cell destruction in vivo.
27. + cytotoxic T-cells in the destruction of pancreatic beta cells in NOD mice. J Immunol 1994, 152:2042-2050.
28. + T-cell clones in vivo. Diabetes 1996, 45:1121-1131.
29. + T cells occurs via the standard lylic mechanism.
30. 30. Kolb H, Kolb-Bachofen V, Roep BO: Autoimmune versus inflammatory type I diabetes: a controversy? Immunol Today 1995, 16:170-172.
31. 31. Kaufman DL, Tian C-SMJ, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehman PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366:69-72.
32. 32. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993, 366:72-75.
33. 33. Tian J, Atkinson MA, Clare-Salzer M, Herschenfeld A, Forsthuber T, Lehman PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996, 183:1561-1567
34. 34. Elliot JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J, Singh B: Immunization with large isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 1994, 43:1494-1499.
35. 35. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990, 39:933-937.
36. 36. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 1996, 93:956-960.
37. 37. Elias D, Cohen IR: Treatment of autoimmune diabetes and Insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995, 44:1132-1138.
38. 38. Bowman MA, Campbell L, Darrow BL, Ellis TM, Suresh A, Atkinson MA: Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes 1996, 45:205-208.
39. 39. Vaysburd M, Lock C, McDevitt H: Prevention of insulin-dependent diabetes mellitus on nonobese diabetic mice by immunogenic but not by tolerated peptides. J Exp Med 1995, 182:697-902.